Bicycle Therapeutics PLC at SVB Securities Global Biopharma Conference (Virtual) Transcript
Good morning, and thanks everyone for joining us. My name is Jonathan Chang. I'm part of the SVB Securities equity research team. It's my pleasure to host the management team of Bicycle. We have with us today, CEO, Kevin Lee; President and CFO, Lee Kalowski. Thanks, guys. CMO, Dominic Smethurst; CSO, Nick Keen; and VP of Capital Markets and Corporate Communications, Dave Borah.
For the investors that are joining us, feel free to submit questions or e-mail them to me at [email protected]. And with that, let's get started.
Would you guys like to -- first of all, thanks for joining us. And would you like to please, briefly introduce the company?
Hi, Jonathan, and many thanks for the introduction. Bicycle is a company which is based on the unique and groundbreaking work of Sir Greg Winter. We work on a technology of constrained bicyclic peptides. I'll ask Nick to explain a little bit about the properties of these molecules in a second.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
